Nucleic-Acid Therapeutic Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the global nucleic-acid therapeutic market looks promising with opportunities in hospitals, and academic and research institutes. The global nucleic-acid therapeutic market is expected to grow with a CAGR of XX% from 2020 to 2025. The major drivers for this market are lower rate of cure for genetic diseases with traditional drugs, rising awareness among people related to human genetics, and increasing power of softwares to mimic human molecular entities such as receptors.
A total of XX figures / charts and XX tables are provided in this more than 150 pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global nucleic-acid therapeutics market report, please download the report brochure.
nucleic-acid therapeutic
In this market, monogenetic disorders is the largest application of nucleic-acid therapeutic. Growth in various segments of the nucleic-acid therapeutic market are given below:
nucleic-acid therapeutic
The study includes trends and forecast for the global nucleic-acid therapeutic market by technology, application, end user, and region as follows:
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
Anti-Sense And Anti-GeneShort Inhibitory SequencesGene Transfer TherapyNucleoside AnalogsRibozymesAptamersOthers
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Monogenetic DisordersMulti-Genetic Disorders
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
HospitalsAcademic & Research InstitutesOthers
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomSpainGermanyFranceAsia PacificChinaIndiaJapanThe Rest of the World Brazil
Some of the nucleic-acid therapeutic companies profiled in this report include Wave Life Sciences, Copernicus Therapeutics, Imugene, Caperna, Phylogica, Protagonist Therapeutics, Benitec Biopharma, EGEN (Expression Genetics), Benitec Biopharma, and BioMedica (Oxford BioMedica).
Within this market, monogenetic disorders will remain the largest segment by application over the forecast period due to rising awareness of people towards genetic disorders.
North America will remain the largest region over the forecast period due to the presence of excellent reimbursment scenario, strong research base, and the rapid development of new drugs and technology.
Features of the Global Nucleic-Acid Therapeutic Market
Market Size Estimates: Global nucleic-acid therapeutics market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global nucleic-acid therapeutics market size by various segments, such as technology, application, and end user in terms of value.Regional Analysis: Global nucleic-acid therapeutics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different technology, application, end user, and region for the global nucleic-acid therapeutics market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global nucleic-acid therapeutics market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global nucleic-acid therapeutics market by technology (anti-sense and anti-gene, short inhibitory sequences, gene transfer therapy, nucleoside analogs, ribozymes, aptamers, and others), application (monogenetic disorders and multi-genetic disorders), end user (hospitals, academic & research institutes, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global nucleic-acid therapeutics market?
Q.5 What are the business risks and threats to the global nucleic-acid therapeutics market?
Q.6 What are the emerging trends in this nucleic-acid therapeutics market and the reasons behind them?
Q.7 What are some changing demands of customers in this nucleic-acid therapeutics market?
Q.8 What are the new developments in this nucleic-acid therapeutics market? Which companies are leading these developments?
Q.9 Who are the major players in this nucleic-acid therapeutics market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this nucleic-acid therapeutics market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global nucleic-acid therapeutics market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Technology (Anti-Sense and Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, and Others), Application (Monogenetic Disorders and Multi-Genetic Disorders), and End User (Hospitals, Academic & Research Institutes, and Others)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the global nucleic-acid therapeutic market looks promising with opportunities in hospitals, and academic and research institutes. The global nucleic-acid therapeutic market is expected to grow with a CAGR of XX% from 2020 to 2025. The major drivers for this market are lower rate of cure for genetic diseases with traditional drugs, rising awareness among people related to human genetics, and increasing power of softwares to mimic human molecular entities such as receptors.
A total of XX figures / charts and XX tables are provided in this more than 150 pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global nucleic-acid therapeutics market report, please download the report brochure.
nucleic-acid therapeutic
In this market, monogenetic disorders is the largest application of nucleic-acid therapeutic. Growth in various segments of the nucleic-acid therapeutic market are given below:
nucleic-acid therapeutic
The study includes trends and forecast for the global nucleic-acid therapeutic market by technology, application, end user, and region as follows:
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
Anti-Sense And Anti-GeneShort Inhibitory SequencesGene Transfer TherapyNucleoside AnalogsRibozymesAptamersOthers
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Monogenetic DisordersMulti-Genetic Disorders
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
HospitalsAcademic & Research InstitutesOthers
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomSpainGermanyFranceAsia PacificChinaIndiaJapanThe Rest of the World Brazil
Some of the nucleic-acid therapeutic companies profiled in this report include Wave Life Sciences, Copernicus Therapeutics, Imugene, Caperna, Phylogica, Protagonist Therapeutics, Benitec Biopharma, EGEN (Expression Genetics), Benitec Biopharma, and BioMedica (Oxford BioMedica).
Within this market, monogenetic disorders will remain the largest segment by application over the forecast period due to rising awareness of people towards genetic disorders.
North America will remain the largest region over the forecast period due to the presence of excellent reimbursment scenario, strong research base, and the rapid development of new drugs and technology.
Features of the Global Nucleic-Acid Therapeutic Market
Market Size Estimates: Global nucleic-acid therapeutics market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global nucleic-acid therapeutics market size by various segments, such as technology, application, and end user in terms of value.Regional Analysis: Global nucleic-acid therapeutics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different technology, application, end user, and region for the global nucleic-acid therapeutics market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global nucleic-acid therapeutics market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global nucleic-acid therapeutics market by technology (anti-sense and anti-gene, short inhibitory sequences, gene transfer therapy, nucleoside analogs, ribozymes, aptamers, and others), application (monogenetic disorders and multi-genetic disorders), end user (hospitals, academic & research institutes, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global nucleic-acid therapeutics market?
Q.5 What are the business risks and threats to the global nucleic-acid therapeutics market?
Q.6 What are the emerging trends in this nucleic-acid therapeutics market and the reasons behind them?
Q.7 What are some changing demands of customers in this nucleic-acid therapeutics market?
Q.8 What are the new developments in this nucleic-acid therapeutics market? Which companies are leading these developments?
Q.9 Who are the major players in this nucleic-acid therapeutics market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this nucleic-acid therapeutics market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global nucleic-acid therapeutics market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Technology (Anti-Sense and Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, and Others), Application (Monogenetic Disorders and Multi-Genetic Disorders), and End User (Hospitals, Academic & Research Institutes, and Others)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Nucleic-Acid Therapeutics Market Trends and Forecast
3.3: Global Nucleic-Acid Therapeutics Market by Technology
3.3.1: Anti-Sense And Anti-Gene
3.3.2: Short Inhibitory Sequences
3.3.3: Gene Transfer Therapy
3.3.4: Nucleoside Analogs
3.3.5: Ribozymes
3.3.6: Aptamers
3.3.7: Others
3.4: Global Nucleic-Acid Therapeutics Market by Application
3.4.1: Monogenetic Disorders
3.4.2: Multi-Genetic Disorders
3.5: Global Nucleic-Acid Therapeutics Market by End User
3.5.1: Hospitals
3.5.2: Academic & Research Institutes
3.5.3: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Nucleic-Acid Therapeutics Market by Region
4.2: North American Nucleic-Acid Therapeutics Market
4.2.1: Market by Technology: Anti-Sense And Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, and Others
4.2.2: Market by Application: Monogenetic Disorders and Multi-Genetic Disorders
4.2.3: Market by End User: Hospitals, Academic & Research Institutes, and Others
4.2.4: The United States Nucleic-Acid Therapeutics Market
4.2.5: The Canadian Nucleic-Acid Therapeutics Market
4.2.6: The Mexican Nucleic-Acid Therapeutics Market
4.3: European Nucleic-Acid Therapeutics Market
4.3.1: Market by Technology: Anti-Sense And Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, and Others
4.3.2: Market by Application: Monogenetic Disorders and Multi-Genetic Disorders
4.3.3: Market by End User: Hospitals, Academic & Research Institutes, and Others
4.3.4: The Nucleic-Acid Therapeutics Market of United Kingdom
4.3.5: The Spanish Nucleic-Acid Therapeutics Market
4.3.6: The German Nucleic-Acid Therapeutics Market
4.3.7: The French Nucleic-Acid Therapeutics Market
4.4: APAC Nucleic-Acid Therapeutics Market
4.4.1: Market by Technology: Anti-Sense And Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, and Others
4.4.2: Market by Application: Monogenetic Disorders and Multi-Genetic Disorders
4.4.3: Market by End User: Hospitals, Academic & Research Institutes, and Others
4.4.4: The Chinese Nucleic-Acid Therapeutics Market
4.4.5: The Indian Nucleic-Acid Therapeutics Market
4.4.6: The Japanese Nucleic-Acid Therapeutics Market
4.5: ROW Nucleic-Acid Therapeutics Market
4.5.1: Market by Technology: Anti-Sense And Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, and Others
4.5.2: Market by Application: Monogenetic Disorders and Multi-Genetic Disorders
4.5.3: Market by End User: Hospitals, Academic & Research Institutes, and Others
4.5.4: Brazilian Nucleic-Acid Therapeutics Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Nucleic-Acid Therapeutics Market by Technology
7.1.2: Growth Opportunities for the Global Nucleic-Acid Therapeutics Market by Application
7.1.3: Growth Opportunities for the Global Nucleic-Acid Therapeutics Market by End User
7.1.4: Growth Opportunities for the Global Nucleic-Acid Therapeutics Market by Region
7.2: Emerging Trends in the Global Nucleic-Acid Therapeutics Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Nucleic-Acid Therapeutics Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Nucleic-Acid Therapeutics Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Wave Life Sciences Ltd.
8.2: Copernicus Therapeutics Inc.
8.3: Imugene
8.4: Caperna
8.5: Phylogica
8.6: Protagonist Therapeutics
8.7: Benitec Biopharma
8.8: EGEN (Expression Genetics)
8.9: Benitec Biopharma
8.10: BioMedica (Oxford BioMedica)
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Nucleic-Acid Therapeutics Market Trends and Forecast
3.3: Global Nucleic-Acid Therapeutics Market by Technology
3.3.1: Anti-Sense And Anti-Gene
3.3.2: Short Inhibitory Sequences
3.3.3: Gene Transfer Therapy
3.3.4: Nucleoside Analogs
3.3.5: Ribozymes
3.3.6: Aptamers
3.3.7: Others
3.4: Global Nucleic-Acid Therapeutics Market by Application
3.4.1: Monogenetic Disorders
3.4.2: Multi-Genetic Disorders
3.5: Global Nucleic-Acid Therapeutics Market by End User
3.5.1: Hospitals
3.5.2: Academic & Research Institutes
3.5.3: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Nucleic-Acid Therapeutics Market by Region
4.2: North American Nucleic-Acid Therapeutics Market
4.2.1: Market by Technology: Anti-Sense And Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, and Others
4.2.2: Market by Application: Monogenetic Disorders and Multi-Genetic Disorders
4.2.3: Market by End User: Hospitals, Academic & Research Institutes, and Others
4.2.4: The United States Nucleic-Acid Therapeutics Market
4.2.5: The Canadian Nucleic-Acid Therapeutics Market
4.2.6: The Mexican Nucleic-Acid Therapeutics Market
4.3: European Nucleic-Acid Therapeutics Market
4.3.1: Market by Technology: Anti-Sense And Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, and Others
4.3.2: Market by Application: Monogenetic Disorders and Multi-Genetic Disorders
4.3.3: Market by End User: Hospitals, Academic & Research Institutes, and Others
4.3.4: The Nucleic-Acid Therapeutics Market of United Kingdom
4.3.5: The Spanish Nucleic-Acid Therapeutics Market
4.3.6: The German Nucleic-Acid Therapeutics Market
4.3.7: The French Nucleic-Acid Therapeutics Market
4.4: APAC Nucleic-Acid Therapeutics Market
4.4.1: Market by Technology: Anti-Sense And Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, and Others
4.4.2: Market by Application: Monogenetic Disorders and Multi-Genetic Disorders
4.4.3: Market by End User: Hospitals, Academic & Research Institutes, and Others
4.4.4: The Chinese Nucleic-Acid Therapeutics Market
4.4.5: The Indian Nucleic-Acid Therapeutics Market
4.4.6: The Japanese Nucleic-Acid Therapeutics Market
4.5: ROW Nucleic-Acid Therapeutics Market
4.5.1: Market by Technology: Anti-Sense And Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, and Others
4.5.2: Market by Application: Monogenetic Disorders and Multi-Genetic Disorders
4.5.3: Market by End User: Hospitals, Academic & Research Institutes, and Others
4.5.4: Brazilian Nucleic-Acid Therapeutics Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Nucleic-Acid Therapeutics Market by Technology
7.1.2: Growth Opportunities for the Global Nucleic-Acid Therapeutics Market by Application
7.1.3: Growth Opportunities for the Global Nucleic-Acid Therapeutics Market by End User
7.1.4: Growth Opportunities for the Global Nucleic-Acid Therapeutics Market by Region
7.2: Emerging Trends in the Global Nucleic-Acid Therapeutics Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Nucleic-Acid Therapeutics Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Nucleic-Acid Therapeutics Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Wave Life Sciences Ltd.
8.2: Copernicus Therapeutics Inc.
8.3: Imugene
8.4: Caperna
8.5: Phylogica
8.6: Protagonist Therapeutics
8.7: Benitec Biopharma
8.8: EGEN (Expression Genetics)
8.9: Benitec Biopharma
8.10: BioMedica (Oxford BioMedica)
